BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37524199)

  • 1. Inactivation of medial or lateral orbitofrontal cortex during fear extinction did not interfere with fear renewal.
    Shih CW; Chang CH
    Neurobiol Learn Mem; 2023 Oct; 204():107800. PubMed ID: 37524199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medial or lateral orbitofrontal cortex activation during fear extinction differentially regulates fear renewal.
    Shih CW; Chang CH
    Behav Brain Res; 2021 Aug; 412():113412. PubMed ID: 34118296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of medial orbitofrontal cortex abolishes fear extinction and interferes with fear expression in rats.
    Hsieh HT; Chang CH
    Neurobiol Learn Mem; 2020 Mar; 169():107170. PubMed ID: 31978551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant orbitofrontal cortical activation interferes with encoding of Pavlovian fear conditioning.
    Sun CF; Chang CH
    Front Behav Neurosci; 2022; 16():981041. PubMed ID: 36072088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activation of the lateral orbitofrontal cortex on regulation of learned fear and extinction.
    Chang YH; Liu SW; Chang CH
    Neurobiol Learn Mem; 2018 Feb; 148():30-37. PubMed ID: 29294382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of lateral orbitofrontal cortex activation on acquisition of fear extinction and neuronal activities in fear circuit.
    Shih CC; Chang YH; Chiou RJ; Chang CH
    Brain Struct Funct; 2022 Sep; 227(7):2529-2541. PubMed ID: 35918458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Cycloserine facilitates fear extinction in adolescent rats and differentially affects medial and lateral prefrontal cortex activation.
    Baker KD; McNally GP; Richardson R
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():262-269. PubMed ID: 29928912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renewal of extinguished fear activates ventral hippocampal neurons projecting to the prelimbic and infralimbic cortices in rats.
    Wang Q; Jin J; Maren S
    Neurobiol Learn Mem; 2016 Oct; 134 Pt A(Pt A):38-43. PubMed ID: 27060752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial prefrontal cortex involvement in the expression of extinction and ABA renewal of instrumental behavior for a food reinforcer.
    Eddy MC; Todd TP; Bouton ME; Green JT
    Neurobiol Learn Mem; 2016 Feb; 128():33-9. PubMed ID: 26723281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit.
    Milad MR; Furtak SC; Greenberg JL; Keshaviah A; Im JJ; Falkenstein MJ; Jenike M; Rauch SL; Wilhelm S
    JAMA Psychiatry; 2013 Jun; 70(6):608-18; quiz 554. PubMed ID: 23740049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrolytic lesions of the medial prefrontal cortex do not interfere with long-term memory of extinction of conditioned fear.
    Garcia R; Chang CH; Maren S
    Learn Mem; 2006; 13(1):14-7. PubMed ID: 16418435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal patterns of c-Fos expression in the medial prefrontal cortex and amygdala after extinction and renewal of conditioned fear.
    Knapska E; Maren S
    Learn Mem; 2009 Aug; 16(8):486-93. PubMed ID: 19633138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder.
    Remijnse PL; Nielen MM; van Balkom AJ; Cath DC; van Oppen P; Uylings HB; Veltman DJ
    Arch Gen Psychiatry; 2006 Nov; 63(11):1225-36. PubMed ID: 17088503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sample.
    McLaughlin NC; Strong D; Abrantes A; Garnaat S; Cerny A; O'Connell C; Fadok R; Spofford C; Rasmussen SA; Milad MR; Greenberg BD
    Behav Brain Res; 2015 Mar; 280():72-7. PubMed ID: 25446749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of fear extinction with deep brain stimulation: evidence for medial orbitofrontal involvement.
    Rodriguez-Romaguera J; Do-Monte FH; Tanimura Y; Quirk GJ; Haber SN
    Neuropsychopharmacology; 2015 Jun; 40(7):1726-33. PubMed ID: 25601229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study.
    Giménez M; Cano M; Martínez-Zalacaín I; Real E; Alonso P; Segalàs C; Munuera J; Kegeles LS; Weinstein JJ; Xu X; Menchón JM; Cardoner N; Soriano-Mas C; Fullana MA
    Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):1003-1014. PubMed ID: 31432262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: a morphometric study.
    Fullana MA; Cardoner N; Alonso P; Subirà M; López-Solà C; Pujol J; Segalàs C; Real E; Bossa M; Zacur E; Martínez-Zalacaín I; Bulbena A; Menchón JM; Olmos S; Soriano-Mas C
    Psychol Med; 2014 Mar; 44(4):845-56. PubMed ID: 23773479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extinction, applied after retrieval of auditory fear memory, selectively increases zinc-finger protein 268 and phosphorylated ribosomal protein S6 expression in prefrontal cortex and lateral amygdala.
    Tedesco V; Roquet RF; DeMis J; Chiamulera C; Monfils MH
    Neurobiol Learn Mem; 2014 Nov; 115():78-85. PubMed ID: 25196703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific roles of the prelimbic cortex, the dorsal CA1, the ventral DG and ventral CA1 of the hippocampus in the fear return evoked by a sub-conditioning procedure in rats.
    Fu J; Xing X; Han M; Xu N; Piao C; Zhang Y; Zheng X
    Neurobiol Learn Mem; 2016 Feb; 128():80-91. PubMed ID: 26768356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtopography of fear memory consolidation and extinction retrieval within prefrontal cortex and amygdala.
    Jacques A; Chaaya N; Hettiarachchi C; Carmody ML; Beecher K; Belmer A; Chehrehasa F; Bartlett S; Battle AR; Johnson LR
    Psychopharmacology (Berl); 2019 Jan; 236(1):383-397. PubMed ID: 30610350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.